Type 2 diabetes treatment pathway comparison
This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN.
Type 2 diabetes: frailty in older people
Summary covers glycaemic targets for older people, priorities for improving high-quality diabetes care, and a useful frailty assessment pathway.
NICE pancreatitis guideline
Summary of NICE guidance on pancreatitis covers managing complications, nutrition support, and referral for specialist treatment.
Pancreatic exocrine insufficiency guideline
What are the signs of pancreatic exocrine insufficiency in diabetes? This concise management algorithm covers symptoms, investigations, and referral.
SIGN type 2 diabetes guideline
This summary provides key recommendations on lifestyle management, treatment options, diabetic CVD, and CKD. Includes a useful treatment algorithm
Educational resources
AWMSG card: Semaglutide 0.25 mg, 0.5 mg and 1 mg solution for injection in pre-filled pen (Ozempic®▼)
Funded by Novo Nordisk Limited
Semaglutide 0.25 mg, 0.5 mg and 1 mg solution for injection in pre-filled pen (Ozempic®▼) SMC No. (2092)
Funded by Novo Nordisk Limited
NICE guideline on diabetes footcare
This CPD activity consists of 8 multiple-choice questions designed to test your knowledge on the management of diabetic foot problems
NICE type 2 diabetes guideline
This CPD activity consists of 10 multiple-choice questions designed to test your knowledge on type 2 diabetes